Summary by Moomoo AI
HuaLing Pharmaceuticals submitted a new securities change monthly report on September 30, 2024, showing that the company's statutory/registered capital and issued shares remained unchanged this month, at $2,000,000,000 and 1,055,588,761 shares, respectively. In addition, there were no new stock option issuances or exercises in the company's stock option plan, with the remaining number of stock options at 52,799,265 shares. The report was presented by the company secretary Yuan Yingxin on October 7, 2024, confirming that all securities issuances or inventory share sales or transfers have been authorized by the board of directors, and comply with relevant listing rules and legal requirements.
